Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia: A postmortem study

Archives of General Psychiatry

Volumn 54, Issue 7, 1997, Pages 649-658

  Goldsmith, Sara K ^a,b   Shapiro, Raymond M ^a,c   Joyce, Jeffrey N ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Sci and Eng Congressional Fellow   (United States)

^c East Ridge Health Systems   (United States)

^d SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; EPIDEPRIDE; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE;

ARTICLE; ASSOCIATION CORTEX; AUTORADIOGRAPHY; DOPAMINE RELEASE; DRUG EFFICACY; HALLUCINATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; RECEPTOR AFFINITY; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; ADULT; AGED; AUDITORY CORTEX; CHEMISTRY; ENTORHINAL CORTEX; FEMALE; IMAGE PROCESSING; MALE; METABOLISM; MIDDLE AGED; VISUAL CORTEX;

ADULT; AGED; AUDITORY CORTEX; AUTORADIOGRAPHY; BENZAMIDES; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TEMPORAL LOBE; VISUAL CORTEX;

EID: 0030611909     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830190077008     Document Type: Article

References (46)

1. Angrist B, Rotrosen J, Gershon S. Differential effects of amphetamine and neuroleptics on negative vs positive symptoms in schizophrenia. Psychopharmacology. 1980;72:17-19.
2. Bowers MB. The role of drugs in the production of schizophreniform psychoses and related disorders. In: Meltzer HV, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:819-832.
3. Snyder SH. Catecholamines in the brain as mediator of amphetamine psychosis. Arch Gen Psychiatry. 1973;130:61-67.
4. Tamminga CA, Schaffer MH, Smith RC, Davis JM. Schizophrenic symptoms improve with apomorphine. Science. 1978;200:567-568.
5. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991;148:1474-1486.
6. Grace AA. Cortical regulation of subcortical systems and its possible relevance to schizophrenia. J Neural Transm. 1993;91:111-134.
7. 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's disease. Neuropsychopharmacology. 1987;1:5-15.
8. 3 receptors and use of antipsychotic drugs in patients with schizophrenia: a postmortem study. Arch Gen Psychiatry. 1997;54:225-232.
9. Gur RE, Jaggi JL, Shtasel DL, Ragland JD, Gur RC. Cerebral blood flow in schizophrenia. Biol Psychiatry. 1994;35:3-15.
10. Tamminga CA, Burrows GH, Chase TN, Alphs LD, Thaker GK. Dopamine neuronal tracts in schizophrenia. Ann N Y Acad Sci. 1988;537:443-450.
11. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase N, Carpenter WT. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry. 1992;49:522-530.
12. Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Copper TB, Laska E, Rostrosen JP. Acute d-amphetamine challenge in schizophrenia. Biol Psychiatry. 1994;36:317-332.
13. Shapiro RM. Regional neuropathology in schizophrenia: where are we? where are we going? Schizophr Res. 1993;10:187-239.
14. Arnold SE, Lee VM, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA. 1991;88:10850-10854.
15. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reduction in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry. 1993;34:529-535.
16. Barbeau D, Liang JJ, Robitaille Y, Quiron R, Srivastava LK. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A. 1995;92:2785-2789.
17. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry. 1993;50:178-187.
18. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry. 1991; 48:625-632.
19. Jacob H, Beckmann H. Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 1986;65:154-161.
20. Jakob H, Beckmann H. Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med. 1989;82:466-469.
21. 2 receptor expression in hippocampus and parahippocampal cortices of human, rat and cat in comparison with tyrosine hydroxylase immunoreactive fibers. Hippocampus. 1994;4:1-20.
22. 2 receptors are organized in bands in normal human temporal cortex. Neuroscience. 1996;74:435-451.
23. Barta PE, Pearlson GD, Powers RE, Richards S, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry. 1990;147:1457-1462.
24. McGuire PK, Shah GMS, Murray RM. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet. 1993;342:703-706.
25. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski, JQ. Prospective clinicopathological studies of schizophrenia: accrual and assessment. Am J Psychiatry. 1995;152:731-737.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
27. Arnold SE, Franz BR, Trojanowski JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging. 1994;15:299-303.
28. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991; 1:103-116.
29. Kane JM. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. Baltimore, Md: Williams & Wilkins; 1989:777-792.
30. 2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J Camp Neurol. 1994;348:94-110.
31. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A. 1994;91:11271-11275.
32. Goldsmith S, Joyce JN. Alterations in the hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry. 1995;37:122-126.
33. 125I autoradiography. J Neurosci Methods. 1990;32:185-192.
34. Roberts SJ, Hanaway J. Atlas of the Human Brain in Section. Philadelphia, Pa: Lea & Febiger; 1971.
35. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoki A, Bunney WE Jr, Jones EG. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52: 258-266.
36. Meador-Woodruff JH, Grandy DK, Van Tol HHM, Damask SP, Little KY, Civelli O, Watson SJ. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology. 1994;10:239-248.
37. Rakic P. Mode of cell migration to the superficial layers of the fetal monkey neocortex. J Comp Neurol. 1972;145:61-84.
38. Reinoso BS, Undie AS, Levit P. Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res. 1996; 43:439-453.
39. 3, and D, dopamine receptors revealed in transfected neuronal cell lines. Proc Natl Acad Sci U S A. 1994;91:649-653.
40. Weinberger DR, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, III. Arch Gen Psychiatry. 1988;45:609-615.
41. Stabenau JR, Pollin W. Heredity and environment in schizophrenia, revisited: the contribution of twin and high-risk studies. J Nerv Ment Dis. 1993;181:290-297.
42. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, Le May M, Wible CG, Hokama H, Martin J, Colemean M, McCarley RW. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. N Engl J Med. 1992;327:604-612.
43. McCarley RW, Shenton ME, O'Donnell BF, Gaux SF, Kikinis R, Nestor G, Jolesz FA. Auditory 300 abnormalities and left superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry. 1993;50:190-197.
44. Penfield W, Perot P. The brains record of auditory and visual experience. Brain. 1963;86:595-696.
45. Joyce JN. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology. 1993;112(suppl):S16-S34.
46. Cleghorn JM, Franco S, Szechtman B, Kaplan RD, Szechtman H, Brown GM, Nahmias C, Garnett ES. Toward a brain map of auditory hallucinations. Am J Psychiatry. 1992;149:1062-1069.